Vectura Group Share Price (VEC)

138.50 -2.50 (-1.77%) delayed: 9:18PM BST
Bid price 138.50 Open price 139.90
Ask price 138.80 Prev close 138.50
High price 139.90 Spread 0.22%
Low price 137.10 Volume 1,113,148

Register now for FREE live Vectura Group share prices, Vectura Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Vectura Group Level 2 Data, indepth research tools and investor commentary for Vectura Group (VEC) and other London Stock Exchange equities.

Vectura Group Share Price Chart

Advanced Charts >>

Register now for FREE Vectura Group share price charts

Vectura Group Share Price Information

Name Vectura Group Epic VEC
Sector Pharmaceuticals & Biotechnology ISIN GB00B01D1K48
Activites Vectura Group plc develops inhaled therapies principally for the treatment of respiratory diseases. Vectura's main products target diseases such as asthma and chronic obstructive pulmonary disease (COPD), a growing market that is currently estimated to be worth in excess of $25bn. Vectura has seven products marketed by its partners and a portfolio of drugs in clinical and pre-clinical development, a number of which have been licensed to major pharmaceutical companies. Vectura has development collaborations and licence agreements with several pharmaceutical companies, including Novartis, Sandoz (the generics arm of Novartis), Baxter and GlaxoSmithKline (GSK). Vectura seeks to develop certain programmes itself where this will optimise value. Vectura's formulation and inhalation technologies are available to other pharmaceutical companies on an out-licensing basis where this complements Vectura's business strategy. Index FTSE 250

Vectura Group Key Numbers

Latest Share Price (p) 138.50 Net Gearing (%) -17.92
Market Capitalisation (£m) 954.42 Gross Gearing (%) 17.01
Shares in issue (m) 676.89 Debt Ratio 8.28
P/E Ratio 117.50 Debt-to-Equity Ratio 0.44
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.21
Dividend Yield (%) 0.00 Price to book value 4.02
Dividend cover (x) 0.00 ROCE (%) -0.73
Earning per share (p) 1.20 EPS Growth (%) 33.33
52 week high / low 200.00 / 122.80 DPS Growth (%) n/a

Vectura Group Director Deals

Dec.Date Type Director Pos No. of Shares
30/09/2016 BUY Andrew Derodra FD 30,000
28/09/2016 EXR Dr Trevor Phillips ED 510,952
28/09/2016 SEXR Dr Trevor Phillips ED 240,841
27/09/2016 BUY Bruno Angelici CH 80,000
27/09/2016 EXR James Ward-Lilley CEO 714,985

More Vectura Group Director Deals >>

Vectura Group Company News

15:30 30/09/2016

Director Deals - Vectura Group PLC (VEC)

Andrew Derodra, Financial Director, bought 30,000 shares in the company on the 30th September 2016 at a price of 137.55p. The Director now holds 333,146 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com

14:09 30/09/2016

Director/PDMR Shareholding

/* */ RNS Number : 3828L Vectura Group plc 30 September 2016     Vectura Group plc Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them (in accordance with the Market...

09:35 28/09/2016

Director Deals - Vectura Group PLC (VEC)

Dr Trevor Phillips, Executive Director, sold post-exercise 240,841 shares in the company on the 27th September 2016 at a price of 139.10p. The Director now holds 491,876 shares. NOTE: Sold to meet tax liabilities etc. Story provided by StockMarketWire.com Director deals data provided by...

More Vectura Group Company News >>

Register now for FREE Vectura Group company news

Vectura Group Share Price Discussions

22 days ago

VECTURA (VEC)

Powered by IST's

Register now for FREE Vectura Group share price discussions